Stocks to Watch: Gemini Explorations, Inc. (OTCBB: GXPI), Poniard Pharmaceuticals Inc. (Nasdaq:PARD) , Nanobac Pharmaceuticals Inc (OTC BB:NNBP) , Javelin Pharmaceuticals, Inc. (AMEX:JAV) , Mountains West Exploration, Inc. (OTC BB:MWXI)
Featured Stock: Gemini Explorations, Inc.
(OTCBB: GXPI)
Current Price (0.08)
Gemini Explorations, Inc. Updates Overview of La Planada Gold Project
Monday September 24, 9:45 am ET
Gold Trading at $735/oz. Presents Potential $2,310,000,000 World Class Gold Deposit
MIAMI, FL----Sep 24, 2007 -- Gemini Explorations, Inc ("Gemini") (OTC BB:GXPI.OB - News) is pleased to release an updated overview of its wholly owned La Planada Gold Project as prepared by Carlos Alberto Vera, Chief Geologist of Minera Primecap Geological Services. The detailed update below supports that over 3,150,000 troy ounces of gold or a gross deposit value of approximately $2,310,000,000 with gold presently trading at $735 per ounce are possible from the La Planada Project.
The La Planada property is located in the
La Planada property is composed of Dagua Group Upper Cretaceous quartzites and siliceous siltstones intruded by a granodiorite plug. Surface exposure is excellent and there were numerous workings at various elevations that can be roughly traced from one elevation to another. The width of the zone (i.e. within the property boundaries) appears much greater than other surrounding properties. There are at least 3 different crosscutting vein sets. The principal vein ranges between 0.4 m and 2.0 m in width. Other veins range between 3 and 20 cm (or more) in width. All carry some sulphides, and free gold was seen in both quartz and with the sulphides. Disseminated sulphides were seen in the host rock sediments, and these will probably contain low-grade gold values, although these have yet to be lab verified. Samples should be taken from two newly reported workings, and of mixed vein and host rock material and it is anticipated that there will be good values gotten from the vein and sulphide material. Panned concentrates from both vein material and tailings showed fine to medium gold.
Assuming the average grade across host rock and vein material on La Planada produces a grade similar to that of surrounding properties there is every reason to think that the deposit could be processed by bulk mining of the entire zone. The ore would be processed using the same method, and probably the same plant, as that proposed for surrounding properties.
The entire La Planada property has excellent rock exposure. The surface could be stripped and then, samples could be taken in vertical channels across both vein and host rock. A series of small drill pads would have to be prepared on the surface of the deposit. They would be collared at 50 m intervals along that line. As drilling progressed more of that face would have to be cleared of vegetation and levelled and a parallel series of pads would have to be built 50 m on either side of the original line of holes. This work will require some blasting of rock to produce those pads. Vertical reverse circulation holes would be drilled from these pads, with holes ranging up to 200 m in depth (if capable) at highest elevation and 100 m in depth at lowest elevation, for a total depth of this first phase of drilling of roughly 1000 m. Dependent on recovery of material, samples would be taken every 2 to 5 m down each hole. Samples would be analyzed for gold by Fire Assay, with A.A. or gravimetric finish. This work will allow an estimate of grade and tonnage for La Planada Project.
Most of the gold is fine. Upon completion of at least an initial round of drilling and assuming favourable results for grade of material, a bench test would be required to determine fineness of the gold, amount of sulphides and what metals are present, and from that what type of processing plant would give the best gold recovery. If there is sufficient coarse gold, a coarse gold circuit (e.g. a vibrating table) would probably be set up. If there is significant gold carried on the surface of sulphides then a sulphide floatation circuit would also be required. However, the bulk of the gold is fine and low grade (1.5 to 4 g/tonne) and is expected to be recovered with a large heap leach pad. Assuming the average grade of 1.5 to 4g/tonne and that sampling to date confirms continuity of mineralization to a depth of 200m, then the entire block could be mined and processed. A block 200 m deep X 300m wide X 400 m long, with an average density of 2.45g/cc would produce 59 millions tonnes of ore with a cut-off grade of 1.5g/tonne gold. That translates to over 3,150,000 troy ounces of gold or a gross deposit value of approximately $2,310,000,000 with gold presently trading at $735 per ounce.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, that although Gemini Explorations, Inc believes the La Planada Gold Project has promising potential, the property is in the early stages of exploration. The project has yet to be shown to contain proven or probable mineral reserves. There can be no assurance that such reserves will be identified on the property, or that, if identified, mineralization may be economically extracted. Minera Primecap Geological Services does not accept responsibility for the use of project data or in the adequacy or accuracy of this release.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the 2005 fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact:
Michael Hill President Gemini Explorations, Inc 8th Floor, 5201 Blue Lagoon Drive Miami , Florida 33126 http://www.geminiexploration.com email: info@geminiexploration.com IR info: 1 877 700 1644
Source: Gemini Explorations, Inc.
For an in-depth analyst report, please visit: www.WallstreetStockReview.com
Poniard Pharmaceuticals Inc.
(Nasdaq:PARD)
Current Price (5.67)
SOUTH SAN FRANCISCO, Calif., Sept. 27 -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD - News), a biopharmaceutical company focused on oncology, today announced that the Company's common shares are now eligible to be included in the NASDAQ Global Market and will begin trading there under the same symbol "PARD" effective Monday, October 1, 2007. Poniard Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of cancer therapy products in the
Nanobac Pharmaceuticals Inc
(OTC BB:NNBP)
Current Price (0.13)
TAMPA, Fla.--Sept 28--Nanobac Pharmaceuticals Inc. (OTCBB:NNBP - News; "Nanobac" or "the Company") is pleased to announce that its Board of Directors has approved an interim financing package that will allow the Company to meet its scientific and business initiatives through the end of the year. This financing is a debt instrument which is being secured by management and should have minimal to no dilution to shareholders. Nanobac Pharmaceuticals, Incorporated, a bio-lifescience company, engages in the discovery and development of products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It offers ?in vitro diagnostic' (IVD) kits, such as assays, antibodies, and reagents for detecting calcifying nanoparticles. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases. Nanobac Pharmaceuticals was founded in 1994 and is headquartered in
Javelin Pharmaceuticals, Inc.
(AMEX:JAV)
Current Price (5.03)
CAMBRIDGE, Mass.--Sept 27--President and founder Fred Mermelstein of Javelin Pharmaceuticals, Inc. (Amex: JAV - News) will discuss, during a presentation at the UBS conference today in New York City, that on September 25, 2007, Javelin was granted a commercially important U.S. patent, enabling greater protection of Javelin's PMI-150 (intranasal ketamine). U.S. Patent Number 7,273,889, entitled: "NMDA Receptor Antagonist Formulation with Reduced Neurotoxicity," extends protection covering Javelin's intranasal ketamine drug candidates into 2023. Javelin Pharmaceuticals, Inc., together with its subsidiaries, engages in the research, development, and commercialization of products for pain relief in the
Mountains West Exploration, Inc.
(OTC BB:MWXI)
Current Price (7.75)
WallStreetStockReview.com is owned and operated by Iron Consulting.
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b),WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive seventy two thousand dollars in 2006 and thirty six thousand in 2007 from Equity Alliance Intl. www.equityallianceir.com for a internet marketing program. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
